Yonglian Zhang

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yonglian Zhang. Retrieved from https://idiyas.com/inventor/yonglian-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Metuchen, NJ (US) (2017 - 2022)
East Brunswick, NJ (US) (2022 - 2024)

Company Filing History:

15 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2017-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use (2025-11-11),

2. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use (2025-09-16),

3. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use (2025-04-01),

4. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use (2024-08-13),

5. 11958864 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors (2024-04-16),

6. 11358711 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors (2022-06-14),

7. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use (2022-04-26),

8. 10829499 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors (2020-11-10),

9. 10544155 - Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors (2020-01-28),

10. 10479801 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors (2019-11-19),

11. 10201533 - Substituted quinolizine derivatives useful as HIV integrase inhibitors (2019-02-12),

12. 10138212 - [object Object] (2018-11-27),

13. 9861620 - Substituted quinolizine derivatives useful as HIV integrase inhibitors (2018-01-09),

14. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors (2017-07-25),

15. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors (2017-07-18),

Title: Innovative Genius: Yonglian Zhang

Introduction: Yonglian Zhang is a prolific inventor based in Metuchen, NJ (US), with an impressive portfolio of 11 patents to his name. His groundbreaking work in the field of pharmaceuticals has led to significant advancements in the treatment and prevention of HIV infections.

Latest Patents: Among his latest patents is the development of Tetracyclic Heterocycle Compounds that serve as potent HIV integrase inhibitors. These compounds, with their unique molecular structure and properties, have shown great promise in combating HIV and improving patient outcomes. Zhang's ingenuity shines through in his ability to create novel solutions to complex medical challenges.

Career Highlights: Yonglian Zhang is a key figure at Merck Sharp & Dohme Corporation, where he continues to drive innovation and excellence in pharmaceutical research. His contributions to the development of cutting-edge medications have not gone unnoticed, and he is widely respected for his dedication to advancing medical science.

Collaborations: Zhang's success is also attributed to his collaborations with talented individuals such as Tao Yu and Thomas H. Graham. Together, they form a formidable team that thrives on creativity, teamwork, and a shared passion for making a positive impact on global healthcare.

Conclusion: In conclusion, Yonglian Zhang stands as a shining example of an inventor whose brilliant mind and unwavering commitment to innovation have transformed the landscape of pharmaceuticals. His work has the potential to save countless lives and pave the way for a healthier future. Zhang's legacy will undoubtedly leave a lasting imprint on the world of medicine for years to come.

Profile summary based on public USPTO records.